Download App

Log in to access Online Inquiry
Company Overview More
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its geographical segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.
Country: Singapore
BFK Pharmesis Intl
0.086-0.011-11.34%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30(FY)2020/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-7.97% 13.98M -- 13.98M -0.71% 13.23M 3.4% 15.19M
-Cash and cash equivalents
-7.97% 13.98M -- 13.98M -0.71% 13.23M 3.4% 15.19M
-Including:Cash
-7.97% 13.98M -- 13.98M -- -- 3.4% 15.19M
Receivables
11.7% 14.1M -- 14.1M -21.38% 11.52M -25.66% 12.62M
-Accounts receivable
11.59% 9.04M -- 9.04M -18.3% 9.68M -27.67% 8.1M
-Gross accounts receivable
11.3% 9.3M -- 9.3M -- -- -27.76% 8.36M
-Bad debt provision
-1.98% -258K -- -258K -- -- 30.68% -253K
-Other receivables
11.91% 5.06M -- 5.06M -34.42% 1.84M -21.75% 4.52M
Inventory
3.2% 8.81M -- 8.81M 15.15% 9.28M 24.12% 8.53M
Prepaid assets
-71.74% 156K -- 156K -37.39% 221K 145.33% 552K
Tax assets-Current
0% 106K -- 106K -0.93% 106K -0.93% 106K
Total current assets
0.39% 37.14M -- 37.14M -5.86% 34.35M -4.82% 37M
Non current assets
Net PPE
2.41% 54.21M -- 54.21M 1.12% 53.22M -1.39% 52.94M
-Gross PP&E
1.5% 112.34M -- 112.34M 1.12% 53.22M 2.04% 110.69M
-Accumulated depreciation
-0.66% -58.13M -- -58.13M -- -- -5.4% -57.75M
Total investment
-- 0 -- 0 -- -- -- 0
-Long-term equity investment
-- 0 -- 0 -- -- -- 0
Goodwill and other intangible assets
0% 1.32M -- 1.32M 0% 1.32M 0% 1.32M
-Goodwill
0% 1.32M -- 1.32M 0% 1.32M 0% 1.32M
Total non current assets
2.35% 55.54M -- 55.54M 1.09% 54.54M -1.36% 54.26M
Total assets
1.55% 92.68M -- 92.68M -1.72% 88.89M -2.79% 91.26M
Liabilities
Current liabilities
Financial liabilities
1.22% 15.39M -- 15.39M -0.11% 15.21M -0.35% 15.21M
-Current debt and capital lease obligation
1.22% 15.39M -- 15.39M -0.11% 15.21M -0.35% 15.21M
-Including:Current debt
0% 15M -- 15M 0% 15M 0% 15M
-Including:Current capital Lease obligation
90.29% 392K -- 392K -7.21% 206K -20.46% 206K
Payables
-7.81% 13.72M -- 13.72M 64.04% 6.2M 20.28% 14.88M
-accounts payable
3.34% 4.43M -- 4.43M 67.5% 6.2M 159.35% 4.29M
-Total tax payable
789.87% 1.41M -- 1.41M -- -- -69.85% 158K
-Other payable
-24.46% 7.89M -- 7.89M -- -- 2.36% 10.44M
Accrued and deferred income
-27.92% 1.68M -- 1.68M -16.68% 8.82M 51.46% 2.33M
Current liabilities
-5.02% 30.79M -- 30.79M 2.16% 30.22M 11.13% 32.42M
Non current liabilities
Non-current financial liabilities
161.62% 1.75M -- 1.75M -20.46% 548K -3.19% 667K
-Long term debt and capital lease obligation
161.62% 1.75M -- 1.75M -20.46% 548K -3.19% 667K
-Including:Long term capital lease obligation
161.62% 1.75M -- 1.75M -20.46% 548K -3.19% 667K
Total non current liabilities
161.62% 1.75M -- 1.75M -20.46% 548K -3.19% 667K
Total liabilities
-1.66% 32.54M -- 32.54M 1.64% 30.77M 10.8% 33.08M
Shareholders'equity
Share capital
0% 83.71M -- 83.71M 0% 83.71M 0% 83.71M
-common stock
0% 83.71M -- 83.71M 0% 83.71M 0% 83.71M
Retained earnings
2.78% -27.76M -- -27.76M -- -28.85M -25.64% -28.55M
Other equity interest
0% -10.47M -- -10.47M -- -10.47M 0% -10.47M
Other reserves
3.25% 11.98M -- 11.98M 145.92% 11.6M 0% 11.6M
Total stockholders'equity
2.08% 57.46M -- 57.46M -4.2% 55.99M -9.38% 56.29M
Noncontrolling interests
42.35% 2.68M -- 2.68M 23.66% 2.12M -0.95% 1.88M
Total equity
3.38% 60.14M -- 60.14M -3.41% 58.12M -9.13% 58.18M
Currency Unit
CNYCNYCNYCNY

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%